Combine barrier, inflammatory and morphology endpoints for candidate follow-up.
TRiCBIO HUMAN ORGANOID STUDYHuman study
Human intestinal organoid IBD-like inflammation study
Human intestinal organoid study showing inflammatory morphology, FITC-Dextran, IL-8 and image-based candidate readouts.
Model & sampleIBD-like inflammation model in human normal intestinal tissue-derived organoids
Study setupCompare vehicle, reference treatment and candidate image readouts under inflammatory conditions
AssaysBright-field morphology, FITC-Dextran, IL-8 and image-derived projected area
010.023% → 0.944%FITC-positive area · matched fields
0277.4 → 106.7Mean IL-8 · pg/mL · 3 measurements/arm
0368 / 112 / 111%Relative area · vehicle/reference/candidate
HUMAN IBD-LIKE STUDY
Inflammation, barrier changes and candidate response in human intestinal organoids
Human intestinal organoids show IBD-like inflammatory and barrier changes. Microscopy, FITC-Dextran and IL-8 readouts document model state and candidate response.
View imageBarrier readout | FITC-positive area in matched fields: 0.023% control, 0.944% challenged. One representative field per group.
Study data
View imageBarrier and inflammatory readouts | FITC-positive area and mean IL-8 rose under inflammatory conditions. FITC uses matched representative fields; IL-8 has three measurements per condition.
Study data
View imageCandidate image readout | Relative area: vehicle 68%, reference 112%, candidate 111%. Each arm is normalized to its own baseline in a representative field.
Study dataHUMAN INTESTINAL ORGANOID CULTURE
View on PubMed ↗Engineered Matrices Enable the Culture of Human Patient-Derived Intestinal Organoids
This peer-reviewed study describes engineered matrices for culturing human patient-derived intestinal organoids and complements the inflammation and barrier assays used in sample-tailored IBD studies.
Human intestinal organoid IBD-like inflammation study
Human intestinal tissue-derived organoids were used to study IBD-like inflammatory and barrier changes. The microscopy and assay figures show the observed response.
Organoid morphology
Bright-field images show structural differences between control and inflammation-challenged organoids.
Barrier and inflammatory readouts
In matched representative fields, FITC-positive area was 0.023% in control and 0.944% under challenge. Mean IL-8 was 77.4 and 106.7 pg/mL, respectively, from three measurements per condition.
Candidate image analysis
Relative projected area was 68% with vehicle, 112% with the reference treatment and 111% with the candidate in representative fields.
Plan the next study
The image comparisons use one representative field per arm. Follow-on studies can add independent samples, doses and functional endpoints matched to the candidate.
INTERPRETATION
From inflammatory barrier changes to candidate testing
FITC and treatment image readouts are representative-field results; IL-8 has three measurements per condition.
Extend candidate studies with independent samples, replicates, doses and functional endpoints.
Related models and services
Choose the right models and services for the next study
Study planning
Build your study from this evidence
Human intestinal organoid IBD-like inflammation and candidate study
Sample source, inflammatory condition, candidate intervention and priority barrier endpoints
Run human-model morphology, FITC-Dextran, IL-8 and image analysis
Images, functional results, methods and integrated interpretation
Compare candidate readouts and plan follow-up validation
Sample source, induction intensity, timing, controls and independent replication
PROJECT DISCUSSION
Discuss a study built around your program
Tell us which model features and readouts matter most. Our scientists will recommend the model, QC plan and study endpoints.